RxDoctor Payments Data

Christian Eversull

Internal Medicine · Stanford, CANPI 1609054006

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,760,011 of the $2,896,305 with a category attached, or 95.3%. Medtronic accounts for 95.3% of it on its own, with 1 other manufacturer making up the rest. 2024 is the largest year on record at $2,789,461, more than ten times the $67,210 reported in 2021. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,896,305in general payments, 2019–2025

Across 9 payments — averaging $321,812 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2.8M
  • Boston Scientific$136K

What the payments were for

  • Royalty or licence$2,760,01195%
  • Education$700%
  • Other$136,2245%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic3$2,760,081
Boston Scientific6$136,224

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,896,305 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →